EGCG 300 mg: Clinical Trials

1 trial of EGCG 300 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow EGCG 300 mg: new trials by email Literature Review of EGCG 300 mg trials Research Report on EGCG 300 mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
EGCG 300 mg, Placebo for EGCG 300 mg, EGCG 600 mg - Idiopathic Pulmonary Fibrosis
Phase 1CompletedHal Chapman122024-02-072026-04-14

Conditions studied

Idiopathic Pulmonary Fibrosis (1)

Sponsors

Hal Chapman (1)

Countries

United States (1)

Top investigators

Fernando Martinez, MD (1)

Results publications

PMID 37116909

NIH funding

R33HL158540 (1)